Literature DB >> 2035996

The diagnosis and treatment of prostate cancer.

G L Andriole1, W J Catalona.   

Abstract

Prostate cancer is the most common cancer among American men and is the third leading cause of cancer death in the United States. Over the past few years, significant advances (e.g. improved prostatic ultrasonography and the discovery of serum prostate-specific antigen) have made it possible to detect prostate cancer at an early stage. In addition, refinements in the treatment both of localized disease (by nerve-sparing radical prostatectomy) and of advanced disease (by novel forms of hormonal therapy) have improved the outlook and quality of life for men with prostate cancer.

Entities:  

Mesh:

Year:  1991        PMID: 2035996     DOI: 10.1146/annurev.me.42.020191.000301

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  2 in total

1.  Two cases of urogenital malignancies in male patients undergoing maintenance haemodialysis.

Authors:  Y Makita; T Iwamoto; K Sagiyama; A Nagaoka; M Kinjo; M Noguchi; K Aramaki; S Okuda; M Fujishima
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

2.  Positive association between preoperative lymphocyte-to-monocyte ratio and risk of the status of positive surgical margins by prostate cancer: results in 497 consecutive patients treated only by radical prostatectomy.

Authors:  Jiatong Zhou; Ranlu Liu
Journal:  Transl Androl Urol       Date:  2021-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.